Form 4: Hims & Hers Health Chief Medical Officer Reports Stock Transactions

Chief Medical Officer of Hims & Hers Health, Patrick Harrison Carroll, reports the vesting and acquisition of 19,707 Class A Common Stock units on June 6, 2024, increasing his direct holdings to 193,587 shares.

Summary

• Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., filed a Form 4 on June 10, 2024.
• The report details a transaction that occurred on June 6, 2024, where 19,707 shares of Class A Common Stock were acquired upon the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Carroll directly owns 193,587 shares of Class A Common Stock.
• The RSUs vested on June 6, 2024, which was the date of the company's 2024 annual stockholders meeting.
• Each RSU represents a contingent right to receive one share of Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to the market regarding the trading activities of company executives and directors.

Comparison to Industry Standards

• Tracking insider transactions is a common practice in financial analysis to gauge management's sentiment about the company's prospects.
• Comparing the volume and frequency of insider transactions with peers like Teladoc Health or GoodRx can provide insights into relative valuation and management confidence.

Stakeholder Impact

• The transaction increases the number of shares held by a key executive, potentially signaling confidence in the company's future performance to shareholders.

Key Dates